2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
5
Esophageal Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Phyllodes Tumor
2
Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Squamous Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Sarcoma
1
Postoperative Complications
1
Oropharyngeal Neoplasms
1
Neoplastic Cells, Circulating
1
Mouth Neoplasms
1
Lymphatic Metastasis
1
Liver Neoplasms
1
Laryngeal Neoplasms
1
Laryngeal Diseases
1
High-Risk Cancer
1
Endometrial Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Cancer Radiotherapy
1
Interventions
Blood Specimen Collection
29
Reverse Transcriptase Polymerase Chain Reaction
7
Flow Cytometry
7
Surgical Procedures, Operative
4
Liquid Biopsy
4
cabazitaxel
3
Trastuzumab
3
Propofol
3
Carboplatin
3
Bevacizumab
3
Standard of Care
2
Spinal Puncture
2
Sevoflurane
2
Positron Emission Tomography Computed Tomography
2
Pirinitramide
2
Neoadjuvant Therapy
2
Morphine
2
Laparoscopy
2
Hematologic Tests
2
Gemcitabine
2
Folfox protocol
2
Epirubicin
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
Cisplatin
2
Cetuximab
2
Capecitabine
2
Aspirin
2
Anesthesia, General
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Cells, Circulating
×
Radiotherapy, Adjuvant
×
Clear all
NCT04902937
2023-11-28
CETC
University of Jena
Recruiting
200 enrolled